GOVERNMENT OF PAKISTAN
MINISTRY OF FINANCE, ECONOMIC AFFAIRS, STATISTICS AND REVENUE
(REVENUE DIVISION)
***
Islamabad, the 10th August, 2000.
NOTIFICATION
(CUSTOMS)
SRO.552(I)/2000. - In exercise of the powers
conferred by section 19 of the Customs Act, 1969 (IV of 1969), and in
suppression of its Notification No. 373(I)/2000, dated the 17th
June, 2000, the Federal Government is pleased to direct that the goods
specified in Tables I, II and III below shall be exempt from so much of the
customs-duty leviable under the First Schedule to the Customs Act, 1969 (IV of
1969), as is in excess of ten per cent ad
valorem, if,-
(a) the raw materials and packing
materials, specified in Table I below, are imported by a manufacturer, approved
by the Director General, Health, Government of Pakistan, under the Drugs Act,
1976 (XXXI of 1976), for manufacture of pharmaceutical products registered as
drugs under the Drugs Act, 1976 (XXXI of 1976), subject to the conditions
specified in that Table;
(b)
the raw materials
and packing materials specified in Table II below, are imported for the
manufacture of drugs registered under the Drugs Act, 1976 (XXXI of 1976),
subject to the conditions specified in that Table; and
(c ) the raw materials,specified in column
(3) of Table III below, are imported for the basic manufacture of
pharmaceutical active ingredients specified in column (2) thereof, subject to
the conditions specified in the said Table:-
Table I
A. List of raw materials:
|
DESCRIPTION (1) |
PCT HEADINGS (2) |
|
Acriflavine
and its salts. |
3824.9099 |
|
Activated
glucronate. |
3824.9099 |
|
Acyclovir. |
3824.9099 |
|
Alkylphenoxypoly
ethanol. |
3824.9099 |
|
Aluminium
hydroxide, Paste/dried/gel/compressed.. |
3824.9099 |
|
Aluminium
hydroxide-magnesium carbonate co-dried. |
3824.9099 |
|
Aluminium
phosphate gel or dried or colloidal
paste. |
3824.9099 |
|
Aluminium
sucrose sulphate |
3824.9099 |
|
Amicarbional. |
3824.9099 |
|
Amidopyrinne/Aminopyrine. |
3824.9099 |
|
Amikacin
sulphate. |
2941.9090 |
|
Amino acid
mixture L form. |
3824.9099 |
|
Aminoglute
thinmide. |
3824.9099 |
|
Ammonium
salt of sulphated alkylphenoxypoly ethanol. |
3402.1290 |
|
Amoxycillin
and its salts excluding Amoxycillin
Trihydrate. |
3824.9099 |
|
Amphotercin-B. |
2941.9090 |
|
Amphotercin-B. |
3824.9099 |
|
Ampicillin
and its salts excluding Ampicillin trihydrate and Ampicillin anhydrous. |
2941.9090 |
|
Ampicillin
sodium + sulbactoum sodium pre-blended/pre-mix. |
2941.9090 |
|
Anti foam emulsion. |
3824.9099 |
|
Attapulgite. |
2508.2000 |
|
Avapyrazone sol. |
2941.9090 |
|
Azaapropazone dihydrate. |
3824.9099 |
|
Azithroneycin dihydrate |
2941.9090 |
|
Aztreonam. |
2941.9090 |
|
Baccampicillin
HCL. |
2941.1020 |
|
Bacitracin
and its salts. |
2941.9090 |
|
Balsam,
Tolu B.P./U.S.P |
1301.9020 |
|
Beccampicillin HCL microcapsule 65-85%. |
3824.9099 |
|
Befunolol
HCL. |
3824.9099 |
|
Benzilic
acid dimethul octyl bromide. |
3824.9099 |
|
Betatab
75. |
3824.9099 |
|
Bezafibrate. |
3824.9099 |
|
Biological
and chemical indicators. |
3824.9099 |
|
Bisacodyl. |
3824.9099 |
|
Brobenzonalidine. |
3824.9099 |
|
Brobenzoxaldine. |
3824.9099 |
|
Brotianide. |
3824.9099 |
|
Butabital. |
2941.9090 |
|
Buzepide mthiodide. |
3824.9099 |
|
Calamine. |
3824.9099 |
|
Calcium
carregeenan. |
3824.9099 |
|
Captopril. |
3824.9099 |
|
Carbachol. |
3824.9099 |
|
Carbencillin
and its salts. |
2941.1020 |
|
Carefcillin. |
2941.1020 |
|
Castor
Oil(injection grade only). |
1515.3000 |
|
Cefaclor. |
2941.9090 |
|
Cefadroxil
monohydrate. |
2941.9090 |
|
Cefaramide
sterile. |
2941.9090 |
|
Cefatoxime
sodium. |
2941.9090 |
|
Cefatrizine
propylene glycolate. |
2941.9090 |
|
Cefazodone
sodium. |
2941.9090 |
|
Cefazolin
sodium. |
2941.9090 |
|
Cefazoline
sodium. |
2941.9090 |
|
Cefixime. |
2941.9090 |
|
Cefizoxime
sodium. |
2941.9090 |
|
Cefoperazone
and its salts. |
2941.9090 |
|
Ceftazadine
pentahydrate(blend). |
3824.9099 |
|
Ceftriaxone
sodium. |
2941.9090 |
|
Cefuroxime. |
2941.9090 |
|
Cefuroxime
axtil granules. |
2941.9090 |
|
Cefuroxime
sodium. |
2941.9090 |
|
Cephalexin sodium. |
2941.9090 |
|
Cephaloridine. |
2941.9090 |
|
Cephradine. |
2941.9090 |
|
Cetomacrogol 1000(Texofor). |
3402.1990 |
|
Cetrimide. |
3808.4090 |
|
Clindamycin. |
2941.9090 |
|
Cloxacillin
and its salts excluding cloxacillin (compacted/powder form for oral use). |
2941.1020 |
|
Coated
granules for moriamin capsules. |
3824.9099 |
|
Colistin
sulphate. |
2941.9090 |
|
Collagen
strip (catgut). |
4206.1000 |
|
Concentrate
of lactoserum brocein of 65% nitrogen. |
3824.9090 |
|
Cylaserine
and its salts. |
2941.9090 |
|
Cytochrome-C. |
3504.0000 |
|
Decoquinate. |
2941.9090 |
|
Decoquinate
6% W/W. |
2941.9090 |
|
Dextran 40 & 70 (pharma grade). |
3913.9000 |
|
Dextrose(injectabale
grade). |
1702.3000 |
|
Dimethicone/simethicone. |
3824.9099 |
|
Dioctahedral
smeltite. |
3802.9000 |
|
Doxepin
and its salts. |
2909.3090 |
|
Enrofloxacin. |
2941.9090 |
|
EPL
substances (essential Phospholipids). |
3824.9099 |
|
Eriodictyon. |
1211.9099 |
|
Erodictyon. |
1211.9099 |
|
Exracepae. |
3824.9099 |
|
Extract
absinthii. |
1302.1990 |
|
Extract
Aconite. |
1302.1990 |
|
Extract
belladonna liq or sicc. |
1302.1990 |
|
Extract
benzoin. |
1302.1990 |
|
Extract
buchu. |
1302.1990 |
|
Extract
capsicum. |
1302.1990 |
|
Extract
colae siccum. |
1302.1990 |
|
Extract
colchicine . |
1302.1990 |
|
Extract
coltsfoot. |
1302.1990 |
|
Extract
ginkgo biloba. |
1302.1990 |
|
Extract
glyoyrrhiza (liquid/siccum). |
1302.1990 |
|
Extract
hyoscyamous. |
1302.1990 |
|
Extract
ipecac. |
1302.1990 |
|
Extract
krameira. |
1302.1990 |
|
Extract
liriosma ovate. |
1302.1990 |
|
Extract
lobelia. |
1302.1990 |
|
Extract
myrrh. |
1302.1990 |
|
Extract
nuxvomica. |
1302.1990 |
|
Extract
pine bark. |
1302.1990 |
|
Extract quassia
+. |
1302.1990 |
|
Extract
rhei. |
1302.1990 |
|
Extract
scillae. |
1302.1990 |
|
Extract
stramonium. |
1302.1990 |
|
Extract
strychnos. |
1302.1990 |
|
Extract
thyme. |
1302.1990 |
|
Extract
valerian. |
1302.1990 |
|
Extract
witch hazel. |
1302.1990 |
|
Extraxct
senega. |
1302.1990 |
|
Eyeless
sucures needles. |
7319.9000 |
|
Flucloxacillin
sodium. |
2941.1020 |
|
Fosfomycin
and its salts. |
2941.9090 |
|
Framycetin
sulphate. |
2941.9090 |
|
Fusidic
acid anhydrous. |
2941.9090 |
|
Fusidic
acid hemihydrate. |
2941.9090 |
|
Gelatin. |
3503.0000 |
|
Gentain
roots/extracts. |
1302.3900 |
|
Gentamicin
and its salts. |
2941.9090 |
|
Gentian
violet. |
3204.1300 |
|
Gentian/
Pluv Gential. |
3204.1300 |
|
Ginkgo
Biloba Extract. |
1302.1990 |
|
Glassine
sleeve. |
4819.5000 |
|
Gluethimide. |
3824.9099 |
|
Glyceryl
mono stearate, distearate and mono ricinoleate. |
3404.9090 |
|
Gramicidin. |
2941.9090 |
|
Gramicidin. |
2941.9090 |
|
Gumbenzoin,
Styrax, Trageacanth, Xanthan. |
1301.9090 |
|
Hemicellulose. |
1302.3900 |
|
Hyoscyamus
leaves. |
1211.9091 |
|
Imidapril
HCL. |
3824.9099 |
|
Intrinsic
factor. |
3824.9099 |
|
Ipecac. |
3824.9099 |
|
Iron-dextran
or sorbitol- citric acid complex. |
3824.9099 |
|
Ispaghule
husk(B.P) chlorzoxazone. |
1404.9090 |
|
Kanamycin
sulphate. |
2941.9090 |
|
Levofloxacin. |
2941.9090 |
|
Lincomycin
and its salts. |
2941.9090 |
|
Loratadine. |
3824.9099 |
|
Losartan
potassium. |
3824.9099 |
|
Lovastatin. |
3824.9099 |
|
Lyophlised saccharomyces boulardii. |
3824.9099 |
|
Macloxamine dihydrogen citrate. |
3824.9099 |
|
Magaldrate gel sulphate. |
3824.9099 |
|
Magaldrate powder USP. |
3824.9099 |
|
Magnesium probencid. |
3824.9099 |
|
Marvelon. |
3824.9099 |
|
Medicamycin acetate fine granules. |
3824.9099 |
|
Methisoprinol. |
3824.9099 |
|
Midecamycin
acetate (fine granules/powder). |
2941.9090 |
|
Midodrine
hydrochloride. |
3824.9099 |
|
Mometasone
fursate. |
3824.9099 |
|
Momochloracarvacrol. |
3824.9099 |
|
Monensin. |
2941.9090 |
|
Mozantel
tartazate. |
3824.9099 |
|
Mucoproteose. |
1302.3900 |
|
Mucpirocin. |
2941.9090 |
|
Myrrh. |
1301.9090 |
|
Neomycin
and its salts. |
2941.9090 |
|
Novobiocin,
its derivatives and salts. |
2941.9090 |
|
Nystatin. |
2941.9090 |
|
O-(2
hydroxyethyl) amylopectin hydrolysate Polly (O-2 hydroxyethyl) starch. |
3504.0000 |
|
Ofeandomycin,
its derivatives and salts. |
2941.9090 |
|
Opalux,
Opadry, Opaspray, Opglos. |
3824.9099 |
|
Ossein
mineral complex. |
3505.0000 |
|
Polymyxine
(polymyxin-b-sulphate ). |
2941.9090 |
|
Polyoxethylene
oleic triglycerides. |
3907.2000 |
|
Polyoxethylene-polymer. |
3907.2000 |
|
Polyvinylpyrrilidone
(pharmaceutical grade). |
3905.9900 |
|
Polyvinylpyrrilidone
iodine. |
3905.9900 |
|
Pregelled/
pregelatinized starch. |
3505.1000 |
|
Pre-mixed
powder of sulbactum sodium and amoxycillin sodium in the ratios 250 mg, 500mg
for sulbamox 750 inj., 500 mg, 1000mg for subamox DS inj. |
2941.9090 |
|
Protamine sulphate. |
3504.0000 |
|
Prune virginian. |
1211.9099 |
|
Raubasine.. |
3824.9099 |
|
Rice
hulls. |
1104.2900 |
|
Rhubarb
leaves/roots. |
1404.9090 |
|
Rifampicin. |
2941.9090 |
|
Rifater
pre-mix. |
3824.9099 |
|
Risperidone. |
3824.9099 |
|
Roxatidine acetate HCL. |
3824.9099 |
|
Roxithromycin. |
2941.9090 |
|
Rufloxacine. |
2941.9090 |
|
Ruscogenine. |
3824.9099 |
|
Secrosteron. |
3824.9099 |
|
Selenium
sulfide with bentonite. |
3824.9099 |
|
Senega. |
3824.9099 |
|
Senidazole. |
3824.9099 |
|
Septocemobin. |
3824.9099 |
|
Seuzm. |
3824.9099 |
|
Silymarine. |
3824.9099 |
|
Simvastatin. |
3824.9099 |
|
Sodium
chloride (injectable grade). |
2501.0090 |
|
Sodium
fusidate. |
2941.9090 |
|
Sodium
lodohepartinate. |
3824.9099 |
|
Sodium
parrolodone crboxylate. |
3824.9099 |
|
Sodium
succinate 6H20. |
3824.9099 |
|
Spfeen
powder. |
3824.9099 |
|
Spironolactone. |
3824.9099 |
|
Spraydried
sodium polyhydoxyaluminium. |
3824.9099 |
|
Streptohyrazine. |
2941.9099 |
|
Sultamicillia tosylate. |
2941.1020 |
|
Sultamicillin. |
2941.1020 |
|
Surfen. |
3824.9099 |
|
Tergitol. |
3824.9099 |
|
Tetanus toxoide. |
3824.9099 |
|
Thiamulin hydrogen fumarate. |
2941.9090 |
|
Tibolone. |
3824.9099 |
|
Tincture asafoetide. |
1302.1910 |
|
Tincture bronchicum. |
1302.1910 |
|
Tincture capsicum. |
1302.1910 |
|
Tincture gimdcifugee. |
1302.1910 |
|
Tincture gimdcifugee. |
1302.1910 |
|
Tincture myrrh. |
1302.1910 |
|
Tincture oucbracho. |
1302.1910 |
|
Tincture primula. |
1302.1910 |
|
Tincture strychors. |
1302.1910 |
|
Tincture thyme. |
1302.1910 |
|
Tobcoat TC. |
3824.9099 |
|
Tobramycin. |
2941.9090 |
|
Tribulus terrestris. |
3824.9099 |
|
Triple antigen concentrate. |
3824.9099 |
|
Trothricin. |
2941.9090 |
|
Tylosin and its salts. |
2941.9090 |
|
Valerine roots. |
1404.9090 |
|
Vancornycin
HCL. |
2941.9090 |
|
Viomycin
sulfate. |
2941.9090 |
|
Virginiamycine. |
3824.9099 |
|
Zinc
bacitrain zinc monomethionine complex. |
3824.9099 |
B. List
of packing materials.
1.
Ampoule cutter.
2.
Aerosol therapy
apparatus and its components.
3.
Aluminum foil
printed, indicating particulars of drug and manufacturer, in roll for
strip/blister packing of
tablets/capsules.
4.
Canaleur and its
caps for infusion sets.
5.
Edible ink.
6. Empty
glass infusion bottle with and without graduation USP II.
7.
Metallic twisters
for flow regulators.
8.
Plastic
nebuliser/dropper bottles for ear, eye and nasal drops with or without
assembly.
9. Plastic nebuliser.
10. Stoppers for I.V. solutions.
11. Neutral glass
cartridges with rubber dices and pungers and aluminium seals.
12. Plastic eye baths.
13. Printed aluminium foil for
sachet/I.V. infusion bag.
14. Printed viskerings.
15. Tear off aluminium seals for
injectables.
16. Non-toxic plastic
bags for I.V. solutions of dextrose and other infusions.
17. Filp off seals for injectable vials.
Conditions:-
(i) The importer, shall make at the time
of clearance from Customs, a declaration on the bill of entry that the goods
will not be used for any purpose other than the manufacture of pharmaceutical
products registered as drugs under the Drugs Act, 1976 (XXXI of 1976); and
(ii) The importer-cum-manufacturer shall
maintain record of the goods imported and the pharmaceutical products
manufactured therefrom and shall produce the same whenever so required by the
appropriate officer of customs or the Director-General, Health, or an officer
authorized by him in that behalf:
Provided that
the exemption in excess of ten per cent ad val., granted by this notification
shall not apply to the import of raw materials and packing materials for the
purpose of manufacture by way of repackaging of drugs:
Provided further that the availability of
the aforementioned facility will be restricted to drugs manufacturers for such
raw materials which have duly been registered and approved by the
Director-General, Health, in accordance with the provisions of the Drugs Act,
1976 (XXXI of 1976). The said facility shall take effect from the date of the
registration of the drug under the Drugs Act, 1976, as per registration certificate
issued by the Ministry of Health to the pharmaceutical manufacturers using any
one or more of the pharmaceutical raw materials mentioned above.
Table II
A. List
of raw materials:
|
DESCRIPTION |
P.C.T HEADINGS |
|
Acesulfame
potassium acetanilide. |
3824.9099 |
|
Acid
undecenoic B.P. |
3824.9099 |
|
Alkyl aryl
sulfonate. |
3402.9099 |
|
Ampnocerin
'K' or 'KS'. |
3824.9099 |
|
Amylopectin.
|
3505.1000 |
|
Anhydrous
di-sodium carbonate. |
2836.3000 |
|
Animal
charcoal (activated carbon). |
3802.1000 |
|
Antifoam
F.D. |
3824.9099 |
|
Benzene
calcium sulphonate. |
2917.3900 |
|
Bevaloid
dispersant. |
2707.9900 |
|
Biotin 1%
in calcium phophate. |
3824.9099 |
|
Bismuth
citrate, subcarbonate, subgallate, subnitrate and subiodide. |
2504.9000 |
|
Butyl
phthalate |
2917.3100 |
|
Capsicum
oleoresin (caposicin). |
3301-9090 |
|
Carboxypolymethylene/caboxy
vinyl polymer(carbopol/carbomer). |
3906-9090 |
|
Carbpoxymethyl
cellulose and its salts. |
3912-3100 |
|
Casein formaldehyde. |
1521-9000 |
|
Catalysts. |
3815.0000 |
|
Catastay
powder. |
3824.9099 |
|
Cellulose
and its derivatives. |
3501-3900 |
|
Cetearyl
octanoate. |
3824.9099 |
|
Cetostearyl
alcohol. |
3823-7010 |
|
Cetylester
wax. |
3404-9090 |
|
Chlorophyll. |
3824.9099 |
|
Coal tar
distillate/solution. |
2706.0000 |
|
Collone
wax. |
3404.9000 |
|
Colophony
resin. |
3906.9090 |
|
Copra
fatty acid diethanolamide. |
3823.7090 |
|
Cremoophor.
|
3402.1310 |
|
Decelite . |
3802.9000 |
|
Diascorea
roots / powder. |
1302.3900 |
|
Dibutylphthalate. |
2917.3100 |
|
Diffutabe
base E2. |
3824.9099 |
|
Dodecylbenzensulphonic
acid salts. |
3402.1110 |
|
Emulsional. |
3823.7090 |
|
Endracite – E. |
3824.9099 |
|
Essences in powder for use in ors(lemon,lime, orange,pineapple,cherry
only). |
2106.9019 |
|
Essential oils (anisi, cinnamon, caraway, cardamom,
nutmeg,lemon,peppermint only). |
3301.9010 |
|
Ethanol. |
2207.1000 |
|
Ethyl
acetate. |
2915-3100 |
|
Ethyl
oleate. |
3824.9099 |
|
Eucalyptus
oil, eucalyptol. |
3301-9010 |
|
Eucerin. |
3824.9099 |
|
Eudragit
all kinds. |
3824.9099 |
|
Explotab. |
3824.9099 |
|
Extract
bitter orange peels. |
2101-2090 |
|
Extract
wild cherry. |
2101-2090 |
|
Ferric
oxide phosphate and pyrophosphate. |
3824.9099 |
|
Food
colour (pharmaceutical grade). |
3205-0000 |
|
Glycofurol. |
3824.9099 |
|
Gum acacia
powder BP. |
1301-9090 |
|
Gum
benjamin BP. |
1301-2000 |
|
Hard fat. |
1501-0090 |
|
Hydorxy
propyl methyl cellulose. |
3912-3100 |
|
Hydrogenated
methyl abietate. |
3806-9000 |
|
Hydrogenated
oil. |
1515-1900 |
|
Igepon
AC-78 and TC-42. |
3402.1110 |
|
Infusorial
earth(Kieselguhr/Hyflo-supercel/celite). |
2512.0000 |
|
Instant
rice. |
Respective heading |
|
Lactose. |
1702-1000 |
|
Lanette
wax. |
2712-9000 |
|
Lanolin
(wool alcohol / fat). |
1505.9000 |
|
Laponite
SLG. |
1505-9000 |
|
Laury
dimethyl aminoxide. |
3823.7090 |
|
Lemon
pippermint only. |
3301.9090 |
|
Lemon,
lime and orange essences(in powder). |
2106.9019 |
|
Linseed
oil. |
1515.1900 |
|
Lucryl
amidoletaine. |
3824.9099 |
|
Lunacera
M. |
3823-7090 |
|
Macrogol
lauryl ether. |
3907-2000 |
|
Malt
extract. |
1901-9010 |
|
Maltadextrin. |
1702.9040 |
|
Megyol -W
mixture. |
1516.2090 |
|
Methyl
methacrylate copolymer(mana copolymer). |
3906.1000 |
|
Methylene
blue. |
3824.9099 |
|
Methyvinyl
ether maleic anhydride copolymer. |
3906.9090 |
|
Microcrystalline
cellulose its derivatives and salts. |
3912.3900 |
|
Microcrystalline
waxes. |
3404.9090 |
|
Migloyl
–812. |
1516.2090 |
|
Monofilament
stainless steel/ Nylon/Polypropylene WP/BPC/USP. |
Respective heading -do- |
|
Orthotolunen
Sulfonamide OTSA. |
2935.0010 |
|
Palm
kernel Oil PEG-6 Complex. |
1513.2110 |
|
Paraffin
hard. |
2712.9000 |
|
PEG-75
Stearate and Glyceryl Stearate. |
3404.2000 |
|
Persnganate,
Sulphate, Succinate. |
3824.9099 |
|
Peuronic
L-62. |
3824.9099 |
|
Pharmacoat. |
3912.3900 |
|
Plaited
(braided) polyester coated BPC/USP. |
Respective heading -do- |
|
Plaited
(braided) silk USP/BPC. |
-do- |
|
Plastibase. |
2710.0099 |
|
Polyethylene
glycol and its derivatives. |
3404.2000 |
|
Polygel. |
3824.9099 |
|
Polyglyceryl
ricinoleates. |
3907.9900 |
|
Polymerized
acrylic acid. |
3824.9099 |
|
Polyoxyethylene.
Glycol/Glycerides/Polyoxyl stearate. |
3404.2000 |
|
Polyoxyl
stearate. |
3824.7090 |
|
Potassium
on charcol 5% catalyst. |
3815.9000 |
|
Prepared
Storax. |
3824.9099 |
|
Primojel. |
3505.1000 |
|
Promulgen. |
3824.9099 |
|
Propandeiol
mona distearate. |
3824.9090 |
|
Propl
gallate . |
3824.9099 |
|
Quassin
solution. |
3824.9099 |
|
Quinaldine
and its salts. |
3824.9099 |
|
Rhizome
galangae. |
1211.9099 |
|
Rhodigel (
food grade). |
3824.9099 |
|
Sandarac. |
3824.9099 |
|
Sesame oil
( for injection). |
3301.2190 |
|
Silicon
emulsion. |
3910.0000 |
|
Sodium
carraghenate. |
3505.1000 |
|
Sodium
croscarmellose. |
3912.3100 |
|
Sodium
formaldehyde hydrogen sulphide. |
3824.9099 |
|
Sodium
lauryl alcohol/sulphate. |
3402.1990 |
|
Sodium
linear alkylatesultonate. |
3824.9099 |
|
Sorbhilan
and its derivatives(tweens and spans). |
3402.1310 |
|
Sorbitol
crystalline powder. |
2905-4400 |
|
Spermacetic. |
1521.9000 |
|
Sterilisable
maize starch. |
1108.1200 |
|
Talc
(pharmaceutical grade ). |
2526.2000 |
|
Tenox-2. |
3824.9099 |
|
Texapon E-
13. |
3402.1910 |
|
Texapon K-
12. |
3402.1910 |
|
Vinylpyrrolidinone
vinyalaectate Copolymer. |
3905.9900 |
|
Viscarin. |
3824.9099 |
|
Wax
emulsifying witepsol. |
3404.9090 |
|
Witepsol. |
3404.9090 |
B. List of packing materials.
1.
Aluminium foil
printed, indicating particulars of drug and manufacturer in roll for wrapping.
2.
Un-printed
aluminium foil with coating of Mylar Polyester adhesive or Surlyn Iononer resin
on one side and vinyl coating on the other side.
3.
Polyester
polyethylene film of polyester (Melinerxor Mylar) and low density poly-ethylene.
4.
Medical
bleached kraft paper metalized on the smooth side and coated on the rough side
with heat seal coating lacquer.
5.
Medical
kraft paper with heat seal coating of EVA resin base; White tag board of
bleached wood pulp.
6.
Neutral Glass Vials
1-2 ml U.S.P-1.
7.
Moulded Glass Vials
U.S.P. Type III (for antibiotics Inj-powder).
8.
Printed Cellophane
Viscose packing and wrapping Flim.
9.
Printed Poly Bags
for infusion sets.
10.
13 mm Rubber
stoppers for injections.
11.
20 mm and 32
mm Rubber stopper for injections.
12. Soft
non-toxic PVC Film/lay flat tube for medical application.
13. PVC non-toxic tubing for medical
application.
14.
Preformed printed pet Slvees.
15.
Glass bottle USP type I.
16.
Pre-printed Polypropylene tubes with tamper
proof closures (with or without dessicant)
indicating particulars of registered drug and manufacturer.
17.
Bottle pack caps FK-28 including a rubber disc and a compound ring for
Haemaccel,
Sterilized.
18.
Lupolen 1840H Q211 for molding haemaccel bottles.
19. Neutral,
clear glass, USP type I (presterilized) close mouth, glass ampoules with long
straight
stem.
Conditions:-
(1) The
manufacturer shall furnish to the Health Division the quantities of the
raw/packing materials along with the details of the drugs to be manufactured
therefrom, and the Director General Health or any other officer authorized in
this behalf will certify for each consignment requirements of raw/packing
materials along with the names of the drugs to be manufactured therefrom in the
Form-I set out below.
(2) At the time of import of raw/packing
materials, the manufacturer shall make a written declaration on each copy of
the bill of entry to the effect that the raw/packing materials have been
imported in accordance with his entitlement in terms of condition (1).
(3) The Collector of Customs shall allow
release of the raw materials against bank guarantee or indemnity bond along with
post-dated cheque equivalent to the amount of customs-duty exempted under this
notification.
(4) The manufacturer shall maintain
records of the materials imported and drugs manufactured therefrom, and shall
produce the same whenever so required by the appropriate officer of customs or
the Health Division.
(5) The manufacturer shall within fifteen months of the date of filing of bill of entry for home consumption relating to the raw/packing materials, apply to the Collector of Customs for discharging the bank guarantee or insurance guarantee, the application being supported by a certificate in the Form-II set out below, issued by the Director General Health or any other officer authorized in this behlaf.
(6) The concession shall take effect from the date of the registration of the drug under the Drugs Act, 1976, as per registration certificate issued by the Ministry of Health to the pharmaceutical manufacturers using any one or more of the pharmaceutical raw materials specified in this notification.
Table III.
|
S.No. |
Products to be manufactured |
List of
raw materials |
(1) (2) (3)
---------------------------------------------------------------------------------------------------------------
(I) (a) Caphalexin Hydrate;and 1. Celite J-2.
(b) Caphradine Hydrate. 2. Charcoal Darko KB.
3. Ethyl Acetate.
(II) (a) Betamethasone; and 1. Norit CN3.
(b) Clobetasol 17-Proprinate. 2. Clarcel flo(Celite).
3. Ethyl Acetate.
4. Methane sulphonyl chloride.
5. Sodium dichromate.
6. Sodium Sulphate Anhydrous.
7. Yeast Extract Powder(Oxoid/Difco).
(III) Salbutamol. 1. Charcoal CN3.
2.
Ethyl
Acetate.
3.
Hyflo
Supercel.
4.
N-Propanol.
5. Sodium Hydroxide B.P.
(IV) Ranitidine Hydrocloride. 1. Celite J-2.
2. Charcoal CN3.
3. Dimethylamine Hydrochloride.
4. Hyflo Supercel.
(V) Trichloroethyl Phosphate. 1. Sodium Mehtoxide.
(VI) Trimethoprim(pure). 1. Sodium Mehtoxide.
2. Charcoal Powder(Activated Carbon).
(VII) Griseofulvin. 1. Antifoam CLRS:
Oil.Substitute.
2. Charcoal Powder SX Plus.
3. Clarcel Flo CR
4. Soya Bean Oil Degummed.
(VIII) Dexamethasone
Sodium Phosphate. 1. Sodium
Hydroxide.
(IX) Cephalexin. 1. Demulsifier.
2.
N-Butyl
Acetate.
(X) Glibenclamide. 1. Cyclohexyl isocynate.
2.
Norit supra
A.
3.
Sodium
hydroxide flakes.
(XI) Pheniramine maleate. 1. Dicalite 4258.
2. Maleic Acid.
3. Norit.
4.
Acetone.
(XII) Frusemide. 1. Lasamide.
2.
Norit SX2.
3.
Trilon B.
(XIII) Cephalexin
and cephradine. 1. Crude
penicillin ‘G’.
(XIV) Ampicillin Trihydrate. 1. Concentrated (Tech Hydrochloric Acid Grade)
2. Concentrated
Ammonium Hydroxide -do-
3. Ethylacetoacetate -do-
4. 2-Ethylhexanoic acid -do-
(XV) Amoxycillin Trihydrate. 1. D-(-)-P-Hydrexy- -do-
phenylglycine
2. Concentrated
Hydrochloric acid -do-
3. Concentrated
Ammonium Hydroxide -do-
(XVI) Cloxacillin sodium 1. Ethyl Acetate.
2. 2-Ethyl Hexanoate Acid.
(XVII) Doclofenac. 1. Cuprous Oxide.
2. Cuprous iodide.
3. T-Butyl methyl ether.
4. Charcoal CN3 .
5. Methylene chloride.
(XVIII) Glibenclamide. 1. Dicalite 4258; and
(XXIX) Frusemide. 1. Dicalite 4258.
(XX) Polygeline.(This is subsequently used for 1. Gelatine No.17471 Acetone.
The formulation of finished drug ‘Haemaccel). 2. Clacium Chloride, Sodium Hydroxide.
3. Hydrochloride Acid,Hexa.
Methylene Di-isocynate.
(XXI) Betamethasone. 1. Acetone.
(XXII) Cephalexin Hydrate/Cephradine Hydrate. -do-
(XXIII) Griseofulvin. -do-
(XXIV) Triclofos. -do-
(XXV) Betamethasone/Clobetasol 17-Propionate. 1. 16-DPA.
(XXVI) Salicylic Acid. 1. Sodium Hydroxide.
(XXVII) Aspirin. 1. Sodium Hydroxide.
(XXVIII) Methyl Salicylate. 1. Sodium Carbonate.
(XXIX) Sodium Salicylate. 1. Activated Carbon.
(XXX) Paracetamol/Para aminophenol. 1. Sodium Nitrite.
(XXXI) Ampicillin Anhydrous. 1. 2-Ethyl Hexanoic Acid.
(XXXII) Alprazolam U.S.P. 1. ALP-Chloride.
(Methanone,(5,chlore-2-2 (3(Chloromethyl)-5-
Methyl-4H-1, 2,4-Triazol-4yl) Phenyl) Phenyl.
2. Ethyl Acetate) Technical Grade Undenatured)
3. Ammonium Hydroxide Solution (Technical Grade 29% NH3).
4. Acetone Extra Pure B.P.N.F.EUP.
(XXXIII) Sulphamethoxazole. 1. Carbon.
2. Isoxamine, (3 Methyl 5 Amino Isozazole)
(XXXIV) Ibuprofen. 1. Sodium Dichoromate.
2. Acetone.
3. Carbon.
(XXXV) Ciprofloxacin. 1. Carbon.
(XXXVI) Norfloxacin. 1. 3 Chloro 4-Fluoro Aniline.
2.
EMME(Diethyl
Ethoxy Methylene Malonate)
3.
Parafin.
4. Acetone.
5. Diethyl sulphate.
6.
Carbon.
7.
Supercel.
(XXXVII) Pefloxacin. 1. Carbon.
(XXXVIII) Pencillin Crude. 1. Corn Steep Liquor.
(Phenylacetamide
pencillanic Acid Potassium salts) 2. Gemex.
3. Filter
Pads.
4. Prod + Floc.
5. Nadar Cento.
6. Linqquad.
7. Liquid Glucose(Dextrose).
8. Stearic Acid.
9. Pharmamedia.
10. N.Butyl Acetate.
11. Acetone.
12. Celite.
13. Activated Carbon.
14. Formaline.
(XXXIX) Pencillin, its derivatives and slats. 1. Carboxy Methyle Cellulose.
Sodium.
2. Filter Pads.
3. N-Butyl Acetate.
4. Acetone.
5. Celite.
6. Activated Carbon.
7. Carbonate.
8. Potassium Carbonate.
9. Sulphuric Acid.
(XL) Magnesium Hydroxide. 1. Magnesium Oxide.
(XLI) Spironolactone. 1. Aldona (17-Hydroxy-3-
OXO-17-a-
Pregna-4-ene; 17 B Carbolactone).
2. Dimethyl formamide.
3. Acetone.
4. Hyflosupered(Diatomeceous Earth).
5. Aldadiene(17-Hydroxy-3-OXO-17-a- _regna-4,6-diene-21-Carboxylic Acid Y-Lactone).
6. Activated Carbon Norit CN3.
(XLII) Haloperidol. 1. Acetone.
2. Hyflosupercel(Diatomaceous Earth).
(XLIII) Ephedrine. 1. Acetone.
2. Filter Aid.
3. Platinum Catalyst.
(XLIV) Santonin . 1. Activated Charcoals.
(XLV) Cephradine. 1. N.N-Dimethyl Acetamide
(DMA)..
2. Cephalosporanic Acid (7-ADCA).
3. Acetone.
4. Activated Carbon.
(XLVI) Cephalexin Hydrate. 1. D (-) Alpha Phenyl Glycine.
2. N.N-Dimethyl Acetamide(DMA).
3. Diethylamine.
4. 7-ADCA.
(XLVII) Penciallin salts. 1. Crude Pencillin.
(XLVIII) Ciprofloxacin Hel. 1. Activated Carbon.
(XLIX) Norfloxacine. 1. Activated carbon.
2. Acetone.
(L) Peefloxacin. 1. Formic acid.
2. Methane.
(LI) Betamethasone products. 1. Triene (21-Acetoxy-17-
Hydroxy-16-Beta-
Methyl-Pregna-1, 49,(II)-Triene-3, 20 Dione.
(LII) Cephradine. 1. Ethylenediaminetetra-acetic
acid
sodium salts(EDTA-NA).
2. Activated Carbon(Animal Porous).
3. Diatomite(Filter aid).
Conditions:-
(1)
The manufacturer
shall furnish to the Ministry of Health or any other officer authorized by the
Ministry of Health in this behalf in the prescribed Form, the details of the
raw materials required for manufacturing pharmaceutical active ingredients who
will get the unit surveyed by an inspection team constituted by the Ministry of
Health and consisting also a member nominated by the Central Board of Revenue
shall certify the annual capacity of the unit for the manufacture of basic
drugs and the total annual requirements of various types of raw materials along
with the quantities required for the basic drugs.
(2)
The manufacturer
shall furnish to the Health Authorities concerned the quantities of the raw
materials imported along with the details of the products or basic drugs
manufactured therefrom and the Director General of Health, Government of
Pakistan, or any other officer authorized by him in this behalf shall certify
for each consignment the requirements of raw materials along with the names of
the products to be manufactured therefrom in Form-I set out below.
(3)
At the time of
import of the raw materials the manufacturer shall submit a declaration in
writing on each copy of the bill of entry to the effect that the raw materials
have been imported in accordance with his entitlement in terms of condition
(1).
(4)
The Collector of
Customs shall allow release of the raw materials against a bank guarantee or
indemnity bond along with post-dated cheque equivalent to the amount of
customs-duty exempted under this notification.
(5)
The manufacturer
shall maintain record of such materials imported and the end products
manufactured therefrom, and shall produce the same on demand by the appropriate
officer of Customs or the Health Authorities.
(6)
The manufacturer
shall, within fifteen months of the date of filing of bill of entry for home-consumption
relating to the raw materials, apply to the Collector of Customs for
discharging the bank guarantee or indemnity bond and post-dated cheque. Such
application shall be supported by a certificate in Form-II set out below,
issued by the Director General Health,
Government of Pakistan, or by any other officer authorized by him in this
behalf to the effect that the basic drug for which the raw materials were
imported has been made out of those materials.
(7)
The Bank Guarantee
or the Indemnity Bond along with post-dated cheque, as the case may be, shall
be discharged by the Collector of Customs on receipt of application from the
partyduly accompanied by a certificate from the Director General of Health,
Government of Pakistan, or by any other officer authorized by him in this
behalf, as required in terms of
condition (5).
I
(Name) ……………………………… Directorate General
of Health, Government of Pakistan, duly
authorized in this behalf by the Director General of Health, Government of
Pakistan, do hereby certify that the raw/packing materials mentioned in the
Schedule below have been imported for the manufacture of pharmaceutical active
ingredients, products, drugs, i.e., ………………………………
(Name of
product)
under
bill of Lading No. ……………dated …………………IGM No… dated ……………………… Index No…………………..
|
Name of the importer-cum-manufacturer and the quantity to be manufactured. |
Name and quantity of the raw/packing materials imported for the manufacture. |
Signature_______________.
Designation.________________.
I (Name) ...........................Directorate
General of Health, Government of Pakistan duly authorized in this behalf by the
Director General of Health, Government of Pakistan, do hereby certify that the
raw/packing materials imported by (………………….............) for the manufacture of
pharmaceutical (Name of the
importer)
active ingredients/products/drugs i.e.
......................under bill of entry No...........dated....……….., IGM No.............. dated.......………Index No........ ................)
according to the details given below have been used for the manufacture/packing
of ______________ in accordance with
the scale laid down by (Name of drug) In case of multiple drugs, add sheet the
Health Division vide certificate No. ________________ dated ______.
|
Name of the importer-cum-manufacturer and the quantity to be manufactured. |
Name and quantity of the raw/packing material imported for the manufacture. |
Signature_________________.
Designation________________.
2. This notification shall be deemed to have taken effect from the 17th June, 2000.
[C.No. 6(4)/2000-CB r/w 36-S
(CB)/2000]
(MIR
FUAD)
Additional
Secretary
Appendix V-Concessions to Privileged Persons and Organisations.
S.No. Page
1. Act No. XX of 1948 relating to United United
Nations (Privileges and
Immunities) Act 1948. 773
Nations
Privileges and Immunities.
2. C.B.R’s C.No 8(61)-Cus-I/51.- Rules regarding import and sale of cars by
diplomats. 777
dated 1-11-1958
3. C.B.R’s C.No. 8(61)Cus-I/51.- Rules regarding sale of goods
by diplomats and other dated
13-5-1960 privileged persons
and organisation.
777
4. C.B.R.’s C.No. 10(34)-Cus.III/58.-
Model Rules for Customs concessions to privileged
personnel
dated 18.4.1963
arriving
under various foreign aid programmes or projects. 778
5. S.R.O.
53(I)/70.-dated 16-3-1970 Goods imported by Rulers of Gulf Sheikhdoms for
personal
use. 779
6. Act
No. IX of 1972, relating to Vienna Diplomatic
and Consular Privileges Act, 1972. 780
Convention.-
dated 12-9-1972
7. Act
No LVIII of 1975 relating to The President’s Salary, Allowances and
Privileges Act, 1975. 793
privileges
of the President.-dated 28-7-1975
8. Act No. LIX of 1975 relating
to The Prime Minister’s Salary, Allowances and Privileges
privileges
of the Prime Minister.- Act,
1975 796
dated 28-7-1975
9. President’s Order No. 5
of 1975.- The
Gover’s Salary, Allowances and Privileges Order,
dated 9-7-1975
1975. 799
10. President’s Order No. 19 of 1978.- The
Acting Governors (Allowances and Privileges)
dated 17-10-1978. Order,
1978. 804
11. S.R.O.
1148(I)/82. - dated
21-11-1982 Goods
imported by organisations in Pakistan from the
church
World Service or the Catholic Services. 804
ACT NO XX OF
1948
Relating to the United
Nations Privileges and Immunities.
(Passed by the
Pakistan Constituent Assembly
(Legislature) (Received the assent of the Governor-General on the
16 June, 1948).
An Act
to give effect to the Convention on the
Privileges and Immunities of the
United Nations.
WHEREAS
it is expendient to give effect to the Convention on the Privileges and
Immunities of the United Nations, and
to enable similar privileges
and immunities to be enjoyed
by the other international
organizations and their
representatives and officials;
It is
hereby enacted as follows:-
(1) This
Act may be called the United Nations
(Privileges and Immunities) Act
1948.
(2) (1) Notwithstanding anything to the contrary contained in any other law, the provisions set out in the Schedule to this Act of the Convention on the Privileges and Immunities, adopted by the General Assembly of the United Nations on the 13th day of February, 1946, shall have the force of law in Pakistan.
(2) The Central Government may, from time to time, by notification in the Official Gazette amend in the Schedul conformity with any amendnents, duly made and adopted, of the provisions of the said Convention set out therin.
(3) Where in pursuance of any international agreement, convention or other instrument it is necessary to accord to any international organization and its representatives and officers privileges and immunities in Pakistan similar to those contained in the provision set out in the Schedule, the Central Government may, by notification in the official Gazette, declare that the provisions set out in the Schedule shall, subject to such modifications, if any, as it may consider necessary or expedient for giving effect to the said agreement, convention or other instrument apply mutatis mutandis to the international organization specified in the notification and its epresentatives and officers, and thereupon the said provision shall apply accordingly and notwithstanding anything to the contrary contained in any other law, shall in such application have the force of law in Pakistan.
(4) The Central Government may make rules for carrying out the purposes of this act.
THE SCHEDULE
(see section 2&3)
ARTICLE I
Judicial Personality
Section1.- The United Nations possess shall judicial
personality. It shall have the capacity:-
(a) to
contract;
(b) to acquire and dispose of
immovable and movable property;
(c) to institute legal proceedings.
ARTICLE II
PRORERTY, FUNDS
AND ASSETS
Section2.- The United Nations, its property and
assets wherever located and by whomsoever held, shall enjoy immunity
from every form of legal process except
in so far as in particular case it has
expressly waived its immunity. It is however, understood that no waiver of
immunity shall extend to any measure of execution.
Section3.- The
primises of the
United Nations shall
be inviolable. The property
and assets of the
United Nations, wherever located
and by whomsoever held, shall be immune From search, requistion, confiscation, expropriation and any other
form of interference, whether by executive, administrative,
judicial or legislative action.
Section4.-
The archives of the United Nations, and in general all documents belonging
to it or held by it, shall be
inviolable wherever located.
Section5.-
Without being restricted by financial controls, regulations or moratoria of any kinds.
(a) The United Nations may hold funds, gold or currency of any kind and operate accounts in any currency;
(b) The United Nations shall be free to transfer its funds, gold or currency from one country to another or within any country and to convert any currency held by it into any other currency.
Section 6.-
In exercising its right under Section 5 above, the United Nations shall pay due regard to any representation
made by Government of any
member in so far as it is considered
that effect can be given to such
representations without detriment
to the interest of the United
Nations.
Section 7.-
The United Nations, its assets,
income and other property shall be:-
(a) exempt from all direct taxes; it is understood, however, that the United Nations will not claim exemption from taxes which are, in fact no more than charges for public utility service.
(b) exempt from customs duties and prohibitions and restrictions on imports and exports in respect of articles imported or exported by the United Nations for its official use. It is understood, however, that articles imported under such exemption will not be sold in the country into which they were imported except under conditions agreed with the Government of that country;
(c) exempt from customs duties prohibitions and restrictions on imports and exports in respect of its publications.
Section
8.- While the United Nations will not, as a general rule, claim exemption from
excise duties and from taxes on the sale
of movable and immovable property which forms part of the price to be paid,
nevertheless when the United Nations is
making important purchases for
official use of property on of which
such duties and taxes have been charged or are chargeable.
Members will, whenever possible, make
appropriate administrative arrangements
for the remission or return of
the amount of duty or tax.
ARTICLE III
FACILITIES IN
RESPECT OF COMMUNICATIONS
Section 9.- The United Nations shall enjoy in
the territory of each Member for its official communications
treatment not less favourable than that accorded by the Government of that
Member to any other Government including its diplomatic mission
in the matter of priorities,
rates and taxes on mails, cables,
telegrams, radiogrammes, telephone, telephotos and other communications;
and press rates for information to the press and radio. No censorship shall be
applied to the
official correspondence and
other official communications of the United Nations.
Section
10.- The United Nations shall have the right to use codes and to despatch and receive its correspondence
by courier or in bags, which shall have the same immunities and
privileges as diplomatic
couriers and bags.
ARTICLE IV
THE REPRESENTATIVE OF MEMBERS
Section 11.-
Representatives of Members to
the Principal and subsidiary organs of the
United Nations and
to conferences convened by
United Nations, shall
while exercising their functions and during their journey to and from the
place of meeting, enjoy the
following privilges and immunities:-
(a) immunity from Personal arrest or detention and from the seizure of their personal baggage, and, in respect of words spoken or written and all acts done by them in their capacity as respresentatives, immunity from legal process of every kind;
(b) inviolability for all papers and documents;
(c) the right to use codes and to receive papers or correspondence by courier or in sealed bags;
(d) exemption in respect of themselves and their spouses from immigration restrictions aliens registration or national service obligations in the state they are visiting or through which they are passing in the exercise of their functions;
(e) the same facilities in respect of currency or exchange restrictions as are accorded to representatives of foregin governments on temporary official missions;
(f) the same immunities and facilities in respect of their personal baggage as are accorded to diplomatic envoys, and also
(g) such other privileges, immunities and facilities not inconsistent with the foregoings as diplomatic envoys enjoy, except that they shall, have no right to claim exemption from customs duties on goods imported (otherwise than as part of their personal baggeg) or from excise duties or sales taxes.
Section
12.- In order to secure, for the
representatives of Members to
the principal and subsidiary organs
of the United Nations and to
conferences convened by the
United Nations, complete freedom of speech and independence in the
discharge of their duties, the immunity
from legal process in respect of words spoken or written and all acts done by
them in discharging their duties shall continue to be accorded,
notwithsatanding that the persons
concerned are no longer the representatives of Members.
Section 13.- Where the incidence of any form of taxation depends upon residence, periods during
which the representatives of
Members to the principal and subsidiary organs of the United Nations and to conferences
convened by the United Nations are present in a state for the discharge of
their duties shall not be considered as period of residence.
Section
14.- Privileges and immunities are accorded to
the representatives of Members
not for the personal benefit of the individuals themselves, but in order to
safeguard the independent exercise
of their functions
in connection with
the United Nations. Consequently a Member the immunity
would impede the course fo justices, and it can be waived
without prejudice to the purpose for which the immunity is accorded.
Section 15.- The provisions
of Section 11, 12 and 13 are
not applicable as between a repesentative and the authorities of the state
of which he is national or of which he is or has been the representative.
Section
16.- In this article the expression
“representatives” shall be deemed
to include all delegates, deputy
delegates, advisers, technical experts and secretaries of delegations.
ARTICLE V
OFFICIALS
Section
17.- The Secretary-General will specify the categories of officials to which the provisions of this Article and
Article VII shall apply. He shall submit these categories to the General Assembly. Thereafter these categories shall be communicated to the
Government of all Members.
The names of the officials included in these categories
shall from time to time be made known to the Government of Members.
Section 18.- Official of the United
Nations shall:-
(a) be immune from legal process in respect of words spoken or written and all acts performed by them in their offical capacity;
(b) be exempt from taxation on the salaries and emoluments paid to them by the United Nations;
(c) be immune from national service obligations;
(d) be immune, together with their spouses and relatives dependent on them, from immigration restrictions and alien registration;
(e) be accorded the same privileges in respect of exchange facilities as are accorded to the officials of comparable ranks forming part of diplomatic missions to the Government concerned;
(f) be given together with their spouses and relatives dependent on them, the same repatriation facilities in time of international crisis as diplomatic envoys;
(g) have the right to import free of duty their furniture and effects at the time of first taking up their post in the country in question.
Section 19.- In addition
to the immunities and privileges specified in Section 18, the
Secretary-General and all Assistant
Secretaries-General shall be accorded
in respect of themselves their spouses and minor children, the privileges
and immunities, exemptions and
facilities accorded to diplomatic
envoys, in accordance with
international law.
Section 20.-Privileges
and immunities are granted to officials in the
interests of the United Nations
and not for the personal benefit of
the individuals themselves. The
Secretary-General shall
have the right and duty to waive the
immunity of any official in case where, in his opinion,
the immunity would impede the course of justice and can be waived without
prejudice to the interests of the United Nations. In the case of the
Secretary-General, the Council shall have the right to waive immunity.
Section 21.- The United Nations shall
cooperate at all times with the
appropriate authorities of Members to facilitate the proper administration of justice, seccure the
observance of police regulations and prevent the
occurrence of any abuse in connection with the privileges, immunities and
facilities mentioned in this Article.
ARTICLE VI
EXPERTS ON MISSION FOR THE
UNITED NATIONS
Section 22.- Experts
(other than officials coming within the scope of Article V) performing missions
for the United Nations shall be accorded such privileges and immunities as are
necessary for the independent
exercise of their functions
during the period of their mission,
including the time spent on journeys in connection with their mission. In
particular they shall be accorded:-
(a) immunity from personal arrest or detention and from seizure of their personal baggage;
(b) in respect of words spoken or written and acts done by them in the course of the performance of their mission immunity from legal process of every kind. This immunity from legal process shall continue to be accorded notwithstanding this the persons concerned are no longer employed on mission for the United Nations;
(c) inviolability for all papers and documents;
(d) for the purpose of their communications with the United Nations, the right to use codes and to receive papers or correspondence by courier or in sealed bags;
(e) the same facilities in respect of currency or exchange restrictions as are accorded to representatives of foreign government on temporary official mission;
(f) the same immuniteies and facilities in respect of their personal baggage as accorded to diplomatic envoys.
Section 23.- Privileges and immunities
are granted to experts in the interests
of the United Nations and not
for the personal benfit of the individuals
themselves. The Secretary-General shall have
the right and the duty to waive the immunity of any expert in any case where, in his opinion,
the immunity would impede the
course of justice and it can be waived
without prejudice to the interests of
the United Nations.
ARTICLE VII
UNITED NATIONS LAISSEZ - PASSER
Section 24.- The United Nations may issue United Nations
laissez-passer to its officials. These laissez-passer shall be recognized and accepted
as valid travel documents
by the
authorites of Members, taking
into account the provisions of Section 25.
Section
25.-Application for visas (where required) from the holders
of United Nations laissez-passer, when accompanied by a certificte that they are travelling on the
business of the United Nations,
shall be dealt
with as speedily
as possible. In addition, such person shall be
granted facilities for
speedy travel.
Section 26.- Similar facilities to
those specified in Section 25
shall be acccorded to experts and other
persons who, though not the holder
of the United Nations laissez-passer, have a certificate that
they are travelling on the business
of the United Nations.
Section 27.- The Secreary-General,
Assistant Secretaries-General and
Directors travelling on the united Nations laissez-passer on the
business of the United Nations
shall be granted the
same facilities as are accorded to diplomatic envoys.
Section 28.- The provisions of this
article may be applied to the comparable
officals of specialized agencies if
the agreements for relationship
made under Article 63 of the Charter so provide.
ARTICLE VIII
SETTLEMENT OF DISPUTES
Section 29.- The United Nations shall make provisions
for appropriate modes of settlement of;-
(a) disputes arising out of contracts or other disputes of a private law character to which the United Nations is a party;
(b) disputes involving any official of the United Nations who by reason of his offical position enjoys immunity, if immunity has not been waived by the Secretary-General.
Sections
30.- All differences arising out of the interpretation or
application of the present
Convention shall be referred to
the international Court of
Justice, unless in any case it is agreed by the parties to have recourse
to another mode of settlement. If a
difference arises between the United Nations on the one hand and a
Member on other hand, a request shall be made for an advisory opinion on any
legal question involved in accordance with Article 96
of the Charter and Article 65 of the Statute of the Court.
The opinion given by the Court shall be
accepted as decisive by the parties.